Bioventus (BVS) Free Cash Flow (2020 - 2026)
Bioventus filings provide 6 years of Free Cash Flow readings, the most recent being $39.7 million for Q4 2025.
- On a quarterly basis, Free Cash Flow rose 115.48% to $39.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $74.4 million, a 96.97% increase, with the full-year FY2025 number at $74.4 million, up 96.97% from a year prior.
- Free Cash Flow hit $39.7 million in Q4 2025 for Bioventus, up from $29.6 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $39.7 million in Q4 2025 to a low of -$21.1 million in Q2 2022.
- Median Free Cash Flow over the past 5 years was $8.6 million (2021), compared with a mean of $6.7 million.
- The widest YoY moves for Free Cash Flow: up 354.1% in 2023, down 539.23% in 2023.
- Bioventus' Free Cash Flow stood at $17.0 million in 2021, then plummeted by 64.13% to $6.1 million in 2022, then surged by 127.84% to $13.9 million in 2023, then surged by 32.71% to $18.4 million in 2024, then surged by 115.48% to $39.7 million in 2025.
- The last three reported values for Free Cash Flow were $39.7 million (Q4 2025), $29.6 million (Q3 2025), and $25.3 million (Q2 2025) per Business Quant data.